» Articles » PMID: 35094247

Alda-1, an Activator of ALDH2, Improves Postresuscitation Cardiac and Neurological Outcomes by Inhibiting Pyroptosis in Swine

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2022 Jan 30
PMID 35094247
Authors
Affiliations
Soon will be listed here.
Abstract

Aldehyde dehydrogenase 2 (ALDH2) has been proven to protect the heart and brain against regional ischemia/reperfusion injury, in which the protective role is related to the inhibition of pyroptosis. In the present study, we investigated whether an ALDH2 activator N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichloro-benzamide (Alda-1) would improve postresuscitation cardiac and neurological outcomes in a clinically relevant swine model of cardiac arrest (CA) and resuscitation. The animal model was established by 8 min of untreated ventricular fibrillation and then 8 min of cardiopulmonary resuscitation (CPR). After restoring spontaneous circulation, the animals were randomly divided to receive either Alda-1 (0.88 mg/kg, n = 6) or saline (n = 5). Postresuscitation hemodynamic parameters, cardiac function, and cardiac and cerebral injuries were periodically measured for a total of 24 h. At 24 h postresuscitation, neurological function was evaluated, and then the animals were sacrificed, and cardiac and cerebral tissue samples were obtained for the measurements of oxidative stress, inflammation and pyroptosis. Consequently, postresuscitation cardiac and neurological dysfunction were significantly improved accompanied with significantly milder cardiac and cerebral injuries in the Alda-1 group compared with the CPR group. In addition, the increase in NLR family pyrin domain-containing 3 inflammasome expression and proinflammatory cytokine production, which indicated the occurrence of inflammatory response, were significantly less in the Alda1 group than in the CPR group. The expression level of gasdermin D used as a protein marker of pyroptosis was also significantly reduced in all resuscitated animals receiving Alda1 treatment. Moreover, the severity of oxidative stress indicated by the changes of 4-hydroxy-2-nonenal and malondialdehyde was significantly decreased in the heart and brain in all animals treated with Alda-1 compared to the CPR group. Thus, Alda-1 mitigated postresuscitation cardiac and neurological dysfunction and injuries possibly by inhibiting oxidative stress-mediated NLRP3 inflammasome activation and pyroptosis in a swine model of CA and resuscitation.

Citing Articles

Mechanisms and preventive measures of ALDH2 in ischemia‑reperfusion injury: Ferroptosis as a novel target (Review).

Han L, Zhai W Mol Med Rep. 2025; 31(4).

PMID: 40017132 PMC: 11876945. DOI: 10.3892/mmr.2025.13470.


Translational approach to assess brain injury after cardiac arrest in preclinical models: a narrative review.

Motta F, Cerrato M, De Giorgio D, Salimbeni A, Merigo G, Magliocca A Intensive Care Med Exp. 2025; 13(1):3.

PMID: 39808393 PMC: 11732829. DOI: 10.1186/s40635-024-00710-y.


Alda-1 attenuation of binge alcohol-caused atrial arrhythmias through a novel mechanism of suppressed c-Jun N-terminal Kinase-2 activity.

Yan J, Khanal S, Cao Y, Ricchiuti N, Nani A, Chen S J Mol Cell Cardiol. 2024; 197:11-19.

PMID: 39395657 PMC: 11664791. DOI: 10.1016/j.yjmcc.2024.10.003.


Multi-omics Study of Hypoxic-Ischemic Brain Injury After Cardiopulmonary Resuscitation in Swine.

Yu S, Xu J, Wu C, Zhu Y, Diao M, Hu W Neurocrit Care. 2024; 42(1):59-76.

PMID: 38937417 DOI: 10.1007/s12028-024-02038-7.


Activation of aldehyde dehydrogenase-2 improves ischemic random skin flap survival in rats.

Zhou T, Wang X, Wang K, Lin Y, Meng Z, Lan Q Front Immunol. 2023; 14:1127610.

PMID: 37441072 PMC: 10335790. DOI: 10.3389/fimmu.2023.1127610.


References
1.
Andersen L, Holmberg M, Berg K, Donnino M, Granfeldt A . In-Hospital Cardiac Arrest: A Review. JAMA. 2019; 321(12):1200-1210. PMC: 6482460. DOI: 10.1001/jama.2019.1696. View

2.
Myat A, Song K, Rea T . Out-of-hospital cardiac arrest: current concepts. Lancet. 2018; 391(10124):970-979. DOI: 10.1016/S0140-6736(18)30472-0. View

3.
Ji Q, Li Y, Wang Y, Wang Z, Fang L, Shen L . Salvianolic Acid B Improves Postresuscitation Myocardial and Cerebral Outcomes in a Murine Model of Cardiac Arrest: Involvement of Nrf2 Signaling Pathway. Oxid Med Cell Longev. 2020; 2020:1605456. PMC: 7352143. DOI: 10.1155/2020/1605456. View

4.
Ji X, Bradley J, Zheng G, Ge W, Xu J, Hu J . Cerebral and myocardial mitochondrial injury differ in a rat model of cardiac arrest and cardiopulmonary resuscitation. Biomed Pharmacother. 2021; 140:111743. DOI: 10.1016/j.biopha.2021.111743. View

5.
Witten L, Gardner R, Holmberg M, Wiberg S, Moskowitz A, Mehta S . Reasons for death in patients successfully resuscitated from out-of-hospital and in-hospital cardiac arrest. Resuscitation. 2019; 136:93-99. PMC: 6476296. DOI: 10.1016/j.resuscitation.2019.01.031. View